ID   AP4AT_HUMAN             Reviewed;         525 AA.
AC   Q96N21; Q6ZQU0; Q6ZSQ9;
DT   15-MAY-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2001, sequence version 1.
DT   11-JUL-2012, entry version 73.
DE   RecName: Full=AP-4 complex accessory subunit tepsin;
DE   AltName: Full=Epsin for AP-4;
DE   AltName: Full=Tetra-epsin;
GN   Name=C17orf56;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Hippocampus, Teratocarcinoma, and Uterus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-356, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,
RA   Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for
RT   efficient phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-333; SER-356 AND
RP   SER-455, PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-51 (ISOFORM 2),
RP   AND MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [5]
RP   INTERACTION WITH AP4B1, AND SUBCELLULAR LOCATION.
RX   PubMed=22472443; DOI=10.1083/jcb.201111049;
RA   Borner G.H., Antrobus R., Hirst J., Bhumbra G.S., Kozik P.,
RA   Jackson L.P., Sahlender D.A., Robinson M.S.;
RT   "Multivariate proteomic profiling identifies novel accessory proteins
RT   of coated vesicles.";
RL   J. Cell Biol. 197:141-160(2012).
CC   -!- SUBUNIT: Associates with the adapter-like complex 4 (AP-4). AP-4
CC       is a heterotetramer composed of two large adaptins (epsilon-type
CC       subunit AP4E1 and beta-type subunit AP4B1), a medium adaptin (mu-
CC       type subunit AP4M1) and a small adaptin (sigma-type AP4S1). Within
CC       this complex, may directly interact with AP4B1.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol. Cytoplasmic vesicle.
CC       Note=Extensively colocalizes with AP-4 in a punctate juxtanuclear
CC       pattern, which likely corresponds to trans-Golgi network. Requires
CC       a functional AP-4 complex for recruitment to vesicle membrane.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q96N21-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q96N21-2; Sequence=VSP_025141, VSP_025142;
CC         Note=Phosphorylated on Ser-51. Ref.1 (BAC87593) sequence is in
CC         conflict in position: 22:R->H;
CC   -!- SIMILARITY: Contains 1 ENTH (epsin N-terminal homology) domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK056090; BAB71091.1; -; mRNA.
DR   EMBL; AK127221; BAC86888.1; -; mRNA.
DR   EMBL; AK128728; BAC87593.1; -; mRNA.
DR   EMBL; BC064483; AAH64483.1; -; mRNA.
DR   IPI; IPI00043327; -.
DR   IPI; IPI00444617; -.
DR   RefSeq; NP_653280.1; NM_144679.2.
DR   UniGene; Hs.631761; -.
DR   ProteinModelPortal; Q96N21; -.
DR   SMR; Q96N21; 15-140.
DR   STRING; Q96N21; -.
DR   PhosphoSite; Q96N21; -.
DR   DMDM; 74732479; -.
DR   PRIDE; Q96N21; -.
DR   Ensembl; ENST00000300714; ENSP00000300714; ENSG00000167302.
DR   Ensembl; ENST00000374769; ENSP00000363901; ENSG00000167302.
DR   GeneID; 146705; -.
DR   KEGG; hsa:146705; -.
DR   UCSC; uc002jzs.2; human.
DR   UCSC; uc002jzu.2; human.
DR   CTD; 146705; -.
DR   GeneCards; GC17M079202; -.
DR   H-InvDB; HIX0014244; -.
DR   H-InvDB; HIX0014245; -.
DR   HGNC; HGNC:26458; C17orf56.
DR   neXtProt; NX_Q96N21; -.
DR   PharmGKB; PA142672239; -.
DR   eggNOG; NOG74274; -.
DR   GeneTree; ENSGT00390000015076; -.
DR   HOGENOM; HOG000049246; -.
DR   HOVERGEN; HBG064281; -.
DR   InParanoid; Q96N21; -.
DR   OMA; LKRNSAF; -.
DR   OrthoDB; EOG4CRM0G; -.
DR   PhylomeDB; Q96N21; -.
DR   NextBio; 85420; -.
DR   ArrayExpress; Q96N21; -.
DR   Bgee; Q96N21; -.
DR   CleanEx; HS_C17orf56; -.
DR   Genevestigator; Q96N21; -.
DR   GO; GO:0016021; C:integral to membrane; IEA:UniProtKB-KW.
DR   GO; GO:0015031; P:protein transport; IEA:UniProtKB-KW.
DR   Gene3D; G3DSA:1.25.40.90; ENTH_VHS; 1.
DR   InterPro; IPR008942; ENTH_VHS.
DR   InterPro; IPR001026; Epsin_dom_N.
DR   Pfam; PF01417; ENTH; 1.
DR   SUPFAM; SSF48464; ENTH_VHS; 1.
DR   PROSITE; PS50942; ENTH; FALSE_NEG.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Cytoplasm;
KW   Cytoplasmic vesicle; Phosphoprotein; Reference proteome.
FT   CHAIN         1    525       AP-4 complex accessory subunit tepsin.
FT                                /FTId=PRO_0000286678.
FT   DOMAIN        8    141       ENTH.
FT   COMPBIAS    193    225       Ser-rich.
FT   COMPBIAS    365    431       Pro-rich.
FT   MOD_RES     254    254       Phosphothreonine (By similarity).
FT   MOD_RES     333    333       Phosphoserine.
FT   MOD_RES     356    356       Phosphoserine.
FT   MOD_RES     455    455       Phosphoserine.
FT   VAR_SEQ       1     85       Missing (in isoform 2).
FT                                /FTId=VSP_025141.
FT   VAR_SEQ      86    175       FFLLILKRNSAFIQEAAAFAGPPDPLHGNSLYQKVRAAAQD
FT                                LGSTLFSDTVLPLAPSQPLGTPPATGMGSQARPHSTLQGFG
FT                                YSKEHGRT -> MGSQARPHSTLQGFGYSKEHGRTGSAGEA
FT                                FLSTIQKAAEVVASAMRPGPESPSTRRLLPRGDTYQPAMMP
FT                                SASHGPPTLGNLLPGAIPGPR (in isoform 2).
FT                                /FTId=VSP_025142.
SQ   SEQUENCE   525 AA;  55137 MW;  B79970A37B801549 CRC64;
     MAAAPPLRDR LSFLHRLPIL LKGTSDDDVP CPGYLFEEIA KISHESPGSS QCLLEYLLSR
     LHSSSGHGKL KVLKILLYLC SHGSSFFLLI LKRNSAFIQE AAAFAGPPDP LHGNSLYQKV
     RAAAQDLGST LFSDTVLPLA PSQPLGTPPA TGMGSQARPH STLQGFGYSK EHGRTAVRHQ
     PGQAGGGWDE LDSGPSSQNS SQNSDLSRVS DSGSHSGSDS HSGASREPGD LAERVEVVAL
     SDCQQELSLV RTVTRGPRAF LSREEAQHFI KACGLLNCEA VLQLLTCHLR GTSECTQLRA
     LCAIASLGSS DLLPQEHILL RTRPWLQELS MGSPGPVTNK ATKILRHFEA SCGQLSPARG
     TSAEPGPTAA LPGPSDLLTD AVPLPGSQVF LQPLSSTPVS SRSPAPSSGM PSSPVPTPPP
     DASPIPAPGD PSEAEARLAE SRRWRPERIP GGTDSPKRGP SSCAWSRDSL FAGMELVACP
     RLVGAGAAAG ESCPDAPRAP QTSSQRTAAK EPPGSEPSAF AFLNA
//
ID   ENTD1_HUMAN             Reviewed;         607 AA.
AC   Q8IYW4; B0QYD5; Q5H9F7; Q96LK3;
DT   04-DEC-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2003, sequence version 1.
DT   13-JUN-2012, entry version 77.
DE   RecName: Full=ENTH domain-containing protein 1;
DE   AltName: Full=Epsin-2B;
GN   Name=ENTHD1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15461802; DOI=10.1186/gb-2004-5-10-r84;
RA   Collins J.E., Wright C.L., Edwards C.A., Davis M.P., Grinham J.A.,
RA   Cole C.G., Goward M.E., Aguado B., Mallya M., Mokrab Y., Huckle E.J.,
RA   Beare D.M., Dunham I.;
RT   "A genome annotation-driven approach to cloning the human ORFeome.";
RL   Genome Biol. 5:R84.1-R84.11(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   MEDLINE=20057165; PubMed=10591208; DOI=10.1038/990031;
RA   Dunham I., Hunt A.R., Collins J.E., Bruskiewich R., Beare D.M.,
RA   Clamp M., Smink L.J., Ainscough R., Almeida J.P., Babbage A.K.,
RA   Bagguley C., Bailey J., Barlow K.F., Bates K.N., Beasley O.P.,
RA   Bird C.P., Blakey S.E., Bridgeman A.M., Buck D., Burgess J.,
RA   Burrill W.D., Burton J., Carder C., Carter N.P., Chen Y., Clark G.,
RA   Clegg S.M., Cobley V.E., Cole C.G., Collier R.E., Connor R.,
RA   Conroy D., Corby N.R., Coville G.J., Cox A.V., Davis J., Dawson E.,
RA   Dhami P.D., Dockree C., Dodsworth S.J., Durbin R.M., Ellington A.G.,
RA   Evans K.L., Fey J.M., Fleming K., French L., Garner A.A.,
RA   Gilbert J.G.R., Goward M.E., Grafham D.V., Griffiths M.N.D., Hall C.,
RA   Hall R.E., Hall-Tamlyn G., Heathcott R.W., Ho S., Holmes S.,
RA   Hunt S.E., Jones M.C., Kershaw J., Kimberley A.M., King A.,
RA   Laird G.K., Langford C.F., Leversha M.A., Lloyd C., Lloyd D.M.,
RA   Martyn I.D., Mashreghi-Mohammadi M., Matthews L.H., Mccann O.T.,
RA   Mcclay J., Mclaren S., McMurray A.A., Milne S.A., Mortimore B.J.,
RA   Odell C.N., Pavitt R., Pearce A.V., Pearson D., Phillimore B.J.C.T.,
RA   Phillips S.H., Plumb R.W., Ramsay H., Ramsey Y., Rogers L., Ross M.T.,
RA   Scott C.E., Sehra H.K., Skuce C.D., Smalley S., Smith M.L.,
RA   Soderlund C., Spragon L., Steward C.A., Sulston J.E., Swann R.M.,
RA   Vaudin M., Wall M., Wallis J.M., Whiteley M.N., Willey D.L.,
RA   Williams L., Williams S.A., Williamson H., Wilmer T.E., Wilming L.,
RA   Wright C.L., Hubbard T., Bentley D.R., Beck S., Rogers J., Shimizu N.,
RA   Minoshima S., Kawasaki K., Sasaki T., Asakawa S., Kudoh J.,
RA   Shintani A., Shibuya K., Yoshizaki Y., Aoki N., Mitsuyama S.,
RA   Roe B.A., Chen F., Chu L., Crabtree J., Deschamps S., Do A., Do T.,
RA   Dorman A., Fang F., Fu Y., Hu P., Hua A., Kenton S., Lai H., Lao H.I.,
RA   Lewis J., Lewis S., Lin S.-P., Loh P., Malaj E., Nguyen T., Pan H.,
RA   Phan S., Qi S., Qian Y., Ray L., Ren Q., Shaull S., Sloan D., Song L.,
RA   Wang Q., Wang Y., Wang Z., White J., Willingham D., Wu H., Yao Z.,
RA   Zhan M., Zhang G., Chissoe S., Murray J., Miller N., Minx P.,
RA   Fulton R., Johnson D., Bemis G., Bentley D., Bradshaw H., Bourne S.,
RA   Cordes M., Du Z., Fulton L., Goela D., Graves T., Hawkins J.,
RA   Hinds K., Kemp K., Latreille P., Layman D., Ozersky P., Rohlfing T.,
RA   Scheet P., Walker C., Wamsley A., Wohldmann P., Pepin K., Nelson J.,
RA   Korf I., Bedell J.A., Hillier L.W., Mardis E., Waterston R.,
RA   Wilson R., Emanuel B.S., Shaikh T., Kurahashi H., Saitta S.,
RA   Budarf M.L., McDermid H.E., Johnson A., Wong A.C.C., Morrow B.E.,
RA   Edelmann L., Kim U.J., Shizuya H., Simon M.I., Dumanski J.P.,
RA   Peyrard M., Kedra D., Seroussi E., Fransson I., Tapia I., Bruder C.E.,
RA   O'Brien K.P., Wilkinson P., Bodenteich A., Hartman K., Hu X.,
RA   Khan A.S., Lane L., Tilahun Y., Wright H.;
RT   "The DNA sequence of human chromosome 22.";
RL   Nature 402:489-495(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 357-607.
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
CC   -!- SIMILARITY: Contains 1 ENTH (epsin N-terminal homology) domain.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAB71688.1; Type=Erroneous initiation;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CR456452; CAG30338.1; -; mRNA.
DR   EMBL; Z82206; CAQ07276.1; -; Genomic_DNA.
DR   EMBL; AL022319; CAQ07276.1; JOINED; Genomic_DNA.
DR   EMBL; AL022353; CAQ07276.1; JOINED; Genomic_DNA.
DR   EMBL; AL022353; CAQ08616.1; -; Genomic_DNA.
DR   EMBL; AL022319; CAQ08616.1; JOINED; Genomic_DNA.
DR   EMBL; Z82206; CAQ08616.1; JOINED; Genomic_DNA.
DR   EMBL; AL022319; CAQ09680.1; -; Genomic_DNA.
DR   EMBL; AL022353; CAQ09680.1; JOINED; Genomic_DNA.
DR   EMBL; Z82206; CAQ09680.1; JOINED; Genomic_DNA.
DR   EMBL; CH471095; EAW60353.1; -; Genomic_DNA.
DR   EMBL; BC033895; AAH33895.1; -; mRNA.
DR   EMBL; AK058150; BAB71688.1; ALT_INIT; mRNA.
DR   IPI; IPI00217897; -.
DR   RefSeq; NP_689725.2; NM_152512.3.
DR   UniGene; Hs.474869; -.
DR   HSSP; Q9Y6I3; 1INZ.
DR   ProteinModelPortal; Q8IYW4; -.
DR   SMR; Q8IYW4; 2-141.
DR   STRING; Q8IYW4; -.
DR   DMDM; 74728393; -.
DR   PRIDE; Q8IYW4; -.
DR   DNASU; 150350; -.
DR   Ensembl; ENST00000325157; ENSP00000317431; ENSG00000176177.
DR   Ensembl; ENST00000381485; ENSP00000370895; ENSG00000176177.
DR   GeneID; 150350; -.
DR   KEGG; hsa:150350; -.
DR   UCSC; uc003ayg.3; human.
DR   CTD; 150350; -.
DR   GeneCards; GC22M040139; -.
DR   HGNC; HGNC:26352; ENTHD1.
DR   HPA; HPA019800; -.
DR   neXtProt; NX_Q8IYW4; -.
DR   PharmGKB; PA145148940; -.
DR   eggNOG; NOG115335; -.
DR   GeneTree; ENSGT00550000074611; -.
DR   HOGENOM; HOG000038004; -.
DR   HOVERGEN; HBG071423; -.
DR   InParanoid; Q8IYW4; -.
DR   OMA; FSTQNVD; -.
DR   OrthoDB; EOG4PZJ6G; -.
DR   PhylomeDB; Q8IYW4; -.
DR   NextBio; 86406; -.
DR   ArrayExpress; Q8IYW4; -.
DR   Bgee; Q8IYW4; -.
DR   CleanEx; HS_ENTHD1; -.
DR   Genevestigator; Q8IYW4; -.
DR   Gene3D; G3DSA:1.25.40.90; ENTH_VHS; 1.
DR   InterPro; IPR008942; ENTH_VHS.
DR   InterPro; IPR013809; Epsin-like_N.
DR   InterPro; IPR001026; Epsin_dom_N.
DR   Pfam; PF01417; ENTH; 1.
DR   SMART; SM00273; ENTH; 1.
DR   SUPFAM; SSF48464; ENTH_VHS; 1.
DR   PROSITE; PS50942; ENTH; 1.
PE   2: Evidence at transcript level;
KW   Coiled coil; Complete proteome; Polymorphism; Reference proteome.
FT   CHAIN         1    607       ENTH domain-containing protein 1.
FT                                /FTId=PRO_0000312179.
FT   DOMAIN        9    141       ENTH.
FT   COILED      543    574       Potential.
FT   VARIANT     109    109       I -> T (in dbSNP:rs17319801).
FT                                /FTId=VAR_037449.
SQ   SEQUENCE   607 AA;  67538 MW;  0FB7FE674E54D4EF CRC64;
     MAFRRQVKNF VKNYSDAEIK VREATSNDPW GPSSSLMLDI SDLTFNTISL SEIMNMLWHR
     LNDHGKNWRH VYKSLTLMDY LIKNGSKKVI QHCREGFCNL QTLKDFQHID EAGKDQGYYI
     REKSKQVITL LMDEPLLCKE REVACRTRQR TSHSILFSKR QLGSSNSLTA CTSAPTPDIS
     ASEKKYKLPK FGRLHNKRNV CKAGLKQEHC QDVHLPTETM LSQETLPLKI HGWKSTEDLM
     TFLDDDPELP LLATPPSIVS PITCLSEAEE VCNLSGADAV PTLSENSPSG QRDVSLDKRS
     DGIFTNTVTE NLLETPLEKQ SAAEGLKTLT ILPACWSSKE EFISPDLRVS KSDSTFHNQA
     SVETLCLSPS FKIFDRVKEI VINKAYQKPA QSSIQMDDKI LKTTTRVSTA SEGASSFSPL
     SMSSPDLASP EKSAHLLSPI LAGPSFWTLS HQQLSSTSFK DEDKTAKLHH SFASRGPVSS
     DVEENDSLNL LGILPNNSDS AKKNISHISS SHWGEFSTQN VDQFIPLSCS GFQSTKDFPQ
     EPEAKNSISV LLREVKRAIA RLHEDLSTVI QELNVINNIL MSMSLNSSQI SQSSQVPQSS
     EGSSDQI
//
ID   EPN1_HUMAN              Reviewed;         576 AA.
AC   Q9Y6I3; Q86ST3; Q9HA18;
DT   16-JAN-2004, integrated into UniProtKB/Swiss-Prot.
DT   03-MAY-2011, sequence version 2.
DT   11-JUL-2012, entry version 117.
DE   RecName: Full=Epsin-1;
DE   AltName: Full=EH domain-binding mitotic phosphoprotein;
DE   AltName: Full=EPS-15-interacting protein 1;
GN   Name=EPN1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), FUNCTION, AND INTERACTION WITH
RP   REPS2.
RC   TISSUE=Brain;
RX   MEDLINE=20027377; PubMed=10557078; DOI=10.1038/sj.onc.1202974;
RA   Morinaka K., Koyama S., Nakashima S., Hinoi T., Okawa K., Iwamatsu A.,
RA   Kikuchi A.;
RT   "Epsin binds to the EH domain of POB1 and regulates receptor-mediated
RT   endocytosis.";
RL   Oncogene 18:5915-5922(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Mammary gland;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   PHOSPHORYLATION AT SER-382, MUTAGENESIS OF SER-382, AND INTERACTION
RP   WITH REPS2; EPS15 AND AP-2 ALPHA SUBUNIT.
RX   PubMed=10764745; DOI=10.1074/jbc.M000521200;
RA   Kariya K., Koyama S., Nakashima S., Oshiro T., Morinaka K.,
RA   Kikuchi A.;
RT   "Regulation of complex formation of POB1/epsin/adaptor protein complex
RT   2 by mitotic phosphorylation.";
RL   J. Biol. Chem. 275:18399-18406(2000).
RN   [6]
RP   INTERACTION WITH RALBP1.
RX   PubMed=12775724; DOI=10.1074/jbc.M302191200;
RA   Rosse C., L'Hoste S., Offner N., Picard A., Camonis J.;
RT   "RLIP, an effector of the Ral GTPases, is a platform for Cdk1 to
RT   phosphorylate epsin during the switch off of endocytosis in mitosis.";
RL   J. Biol. Chem. 278:30597-30604(2003).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-494, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [8]
RP   INTERACTION WITH AP2B1, AND MUTAGENESIS OF PHE-404.
RX   PubMed=16516836; DOI=10.1016/j.devcel.2006.01.016;
RA   Edeling M.A., Mishra S.K., Keyel P.A., Steinhauser A.L., Collins B.M.,
RA   Roth R., Heuser J.E., Owen D.J., Traub L.M.;
RT   "Molecular switches involving the AP-2 beta2 appendage regulate
RT   endocytic cargo selection and clathrin coat assembly.";
RL   Dev. Cell 10:329-342(2006).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-494, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17924679; DOI=10.1021/pr070152u;
RA   Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.;
RT   "Improved titanium dioxide enrichment of phosphopeptides from HeLa
RT   cells and high confident phosphopeptide identification by cross-
RT   validation of MS/MS and MS/MS/MS spectra.";
RL   J. Proteome Res. 6:4150-4162(2007).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-435; SER-454; THR-460;
RP   THR-464 AND THR-494, AND MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-454, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Embryonic kidney;
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-419; SER-420; SER-435;
RP   SER-454; THR-460 AND THR-470, AND MASS SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [13]
RP   STRUCTURE BY NMR OF 1-144.
RX   PubMed=12836669; DOI=10.1023/A:1011397007366;
RA   Koshiba S., Kigawa T., Kikuchi A., Yokoyama S.;
RT   "Solution structure of the epsin N-terminal homology (ENTH) domain of
RT   human epsin.";
RL   J. Struct. Funct. Genomics 2:1-8(2002).
CC   -!- FUNCTION: Binds to membranes enriched in phosphatidylinositol 4,5-
CC       bisphosphate (PtdIns(4,5)P2). Modifies membrane curvature and
CC       facilitates the formation of clathrin-coated invaginations (By
CC       similarity). Regulates receptor-mediated endocytosis.
CC   -!- SUBUNIT: Monomer. Binds clathrin, ZBTB16/ZNF145 and ITSN1. Binds
CC       ubiquitinated proteins (By similarity). Binds REPS2, EPS15, AP2A1
CC       and AP2A2. Interacts with RALBP1 in a complex also containing NUMB
CC       and TFAP2A during interphase and mitosis. Interacts with AP2B1.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm (By similarity). Cell membrane;
CC       Peripheral membrane protein (By similarity). Nucleus (By
CC       similarity). Membrane, clathrin-coated pit (By similarity).
CC       Note=Associated with the cytoplasmic membrane at sites where
CC       clathrin-coated pits are forming. Colocalizes with clathrin and
CC       AP-2 in a punctate pattern on the plasma membrane. Detected in
CC       presynaptic nerve terminals and in Golgi stacks. May shuttle to
CC       the nucleus when associated with ZBTB16/ZNF145 (By similarity).
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q9Y6I3-2; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9Y6I3-1; Sequence=VSP_041010, VSP_041011;
CC         Note=Ref.1 (AAD38326) sequence differs from that shown due to a
CC         frameshift in position 98;
CC       Name=3;
CC         IsoId=Q9Y6I3-3; Sequence=VSP_041011, VSP_041012;
CC         Note=May be due to a competing donor splice site. No
CC         experimental confirmation available;
CC   -!- DOMAIN: The NPF repeat domain is involved in EPS15 binding.
CC   -!- DOMAIN: The DPW repeat domain is involved in AP2A2 and clathrin
CC       binding.
CC   -!- DOMAIN: The [DE]-X(1,2)-F-X-X-[FL]-X-X-X-R motif mediates
CC       interaction with the AP-2 complex subunit AP2B1 (By similarity).
CC   -!- PTM: Phosphorylated on serine and/or threonine residues in mitotic
CC       cells. Phosphorylation reduces interaction with REPS2, AP-2 and
CC       the membrane fraction. Depolarization of synaptosomes results in
CC       dephosphorylation.
CC   -!- PTM: Ubiquitinated (By similarity).
CC   -!- SIMILARITY: Belongs to the epsin family.
CC   -!- SIMILARITY: Contains 1 ENTH (epsin N-terminal homology) domain.
CC   -!- SIMILARITY: Contains 3 UIM (ubiquitin-interacting motif) repeats.
CC   -!- WEB RESOURCE: Name=Protein Spotlight; Note=The bubble's bend -
CC       Issue 42 of January 2004;
CC       URL="http://web.expasy.org/spotlight/back_issues/sptlt042.shtml";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF073727; AAD38326.1; ALT_FRAME; mRNA.
DR   EMBL; AK022454; BAB14041.1; -; mRNA.
DR   EMBL; AC008735; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC010525; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC044651; AAH44651.1; -; mRNA.
DR   IPI; IPI00027082; -.
DR   IPI; IPI00397365; -.
DR   IPI; IPI00647389; -.
DR   RefSeq; NP_001123543.1; NM_001130071.1.
DR   RefSeq; NP_001123544.1; NM_001130072.1.
DR   RefSeq; NP_037465.2; NM_013333.3.
DR   UniGene; Hs.279953; -.
DR   PDB; 1INZ; NMR; -; A=1-144.
DR   PDBsum; 1INZ; -.
DR   ProteinModelPortal; Q9Y6I3; -.
DR   SMR; Q9Y6I3; 1-158.
DR   IntAct; Q9Y6I3; 4.
DR   MINT; MINT-110599; -.
DR   STRING; Q9Y6I3; -.
DR   PhosphoSite; Q9Y6I3; -.
DR   DMDM; 41017059; -.
DR   PRIDE; Q9Y6I3; -.
DR   DNASU; 29924; -.
DR   Ensembl; ENST00000085079; ENSP00000085079; ENSG00000063245.
DR   Ensembl; ENST00000270460; ENSP00000270460; ENSG00000063245.
DR   Ensembl; ENST00000411543; ENSP00000406209; ENSG00000063245.
DR   GeneID; 29924; -.
DR   KEGG; hsa:29924; -.
DR   UCSC; uc002qlv.3; human.
DR   UCSC; uc002qlw.3; human.
DR   UCSC; uc002qlx.3; human.
DR   CTD; 29924; -.
DR   GeneCards; GC19P056186; -.
DR   H-InvDB; HIX0202721; -.
DR   HGNC; HGNC:21604; EPN1.
DR   HPA; CAB009729; -.
DR   MIM; 607262; gene.
DR   neXtProt; NX_Q9Y6I3; -.
DR   PharmGKB; PA134860916; -.
DR   eggNOG; NOG263730; -.
DR   GeneTree; ENSGT00550000074611; -.
DR   HOGENOM; HOG000008298; -.
DR   HOVERGEN; HBG006690; -.
DR   KO; K12471; -.
DR   OMA; SASDPWT; -.
DR   OrthoDB; EOG4SF97B; -.
DR   PhylomeDB; Q9Y6I3; -.
DR   Reactome; REACT_111102; Signal Transduction.
DR   Reactome; REACT_116125; Disease.
DR   EvolutionaryTrace; Q9Y6I3; -.
DR   NextBio; 52535; -.
DR   ArrayExpress; Q9Y6I3; -.
DR   Bgee; Q9Y6I3; -.
DR   CleanEx; HS_EPN1; -.
DR   Genevestigator; Q9Y6I3; -.
DR   GermOnline; ENSG00000063245; Homo sapiens.
DR   GO; GO:0005905; C:coated pit; IEA:UniProtKB-SubCell.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0008289; F:lipid binding; IEA:UniProtKB-KW.
DR   GO; GO:0006897; P:endocytosis; TAS:ProtInc.
DR   GO; GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0042059; P:negative regulation of epidermal growth factor receptor signaling pathway; TAS:Reactome.
DR   Gene3D; G3DSA:1.25.40.90; ENTH_VHS; 1.
DR   InterPro; IPR008942; ENTH_VHS.
DR   InterPro; IPR013809; Epsin-like_N.
DR   InterPro; IPR001026; Epsin_dom_N.
DR   InterPro; IPR003903; Ubiquitin-int_motif.
DR   Pfam; PF01417; ENTH; 1.
DR   Pfam; PF02809; UIM; 2.
DR   SMART; SM00273; ENTH; 1.
DR   SMART; SM00726; UIM; 3.
DR   SUPFAM; SSF48464; ENTH_VHS; 1.
DR   PROSITE; PS50942; ENTH; 1.
DR   PROSITE; PS50330; UIM; 3.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell membrane; Coated pit;
KW   Complete proteome; Cytoplasm; Endocytosis; Lipid-binding; Membrane;
KW   Nucleus; Phosphoprotein; Reference proteome; Repeat; Ubl conjugation.
FT   CHAIN         1    576       Epsin-1.
FT                                /FTId=PRO_0000074513.
FT   DOMAIN       12    144       ENTH.
FT   REPEAT      183    202       UIM 1.
FT   REPEAT      208    227       UIM 2.
FT   REPEAT      233    252       UIM 3.
FT   REPEAT      274    276       1.
FT   REPEAT      294    296       2.
FT   REPEAT      306    308       3.
FT   REPEAT      319    321       4.
FT   REPEAT      332    334       5.
FT   REPEAT      349    351       6.
FT   REPEAT      367    369       7.
FT   REPEAT      377    379       8.
FT   REPEAT      502    504       1.
FT   REPEAT      518    520       2.
FT   REPEAT      572    574       3.
FT   REGION      274    379       8 X 3 AA repeats of [ED]-P-W.
FT   REGION      502    574       3 X 3 AA repeats of N-P-F.
FT   MOTIF       402    411       [DE]-X(1,2)-F-X-X-[FL]-X-X-X-R motif.
FT   COMPBIAS    267    573       Ala/Gly/Pro-rich.
FT   BINDING       8      8       Phosphatidylinositol lipid headgroup (By
FT                                similarity).
FT   BINDING      11     11       Phosphatidylinositol lipid headgroup (By
FT                                similarity).
FT   BINDING      25     25       Phosphatidylinositol lipid headgroup (By
FT                                similarity).
FT   BINDING      30     30       Phosphatidylinositol lipid headgroup (By
FT                                similarity).
FT   BINDING      63     63       Phosphatidylinositol lipid headgroup (By
FT                                similarity).
FT   BINDING      73     73       Phosphatidylinositol lipid headgroup (By
FT                                similarity).
FT   MOD_RES     382    382       Phosphoserine; by CDK1.
FT   MOD_RES     419    419       Phosphoserine.
FT   MOD_RES     420    420       Phosphoserine.
FT   MOD_RES     435    435       Phosphoserine.
FT   MOD_RES     454    454       Phosphoserine.
FT   MOD_RES     460    460       Phosphothreonine.
FT   MOD_RES     464    464       Phosphothreonine.
FT   MOD_RES     470    470       Phosphothreonine.
FT   MOD_RES     494    494       Phosphothreonine.
FT   VAR_SEQ       1      1       M -> MGDQSWLWNQAAPGVRSPVFACSVEKGNVPLVLSEH
FT                                LAHSRDPGSGAVRFLISPEPWASAILGTSGLLASPVLPAAL
FT                                DAVTCQHLPQPSSGSRPISPRIGALCPLLLQPGTM (in
FT                                isoform 2).
FT                                /FTId=VSP_041010.
FT   VAR_SEQ     202    226       Missing (in isoform 2 and isoform 3).
FT                                /FTId=VSP_041011.
FT   VAR_SEQ     393    393       Missing (in isoform 3).
FT                                /FTId=VSP_041012.
FT   MUTAGEN     382    382       S->A: Abolishes phosphorylation by CDK1.
FT   MUTAGEN     382    382       S->D: Abolishes phosphorylation by CDK1
FT                                and reduces REPS2 binding.
FT   MUTAGEN     404    404       F->A: Reduces interaction with AP2B1.
FT   HELIX        20     27
FT   HELIX        39     47
FT   HELIX        51     62
FT   HELIX        63     65
FT   HELIX        72     86
FT   HELIX        90     98
FT   HELIX       100    108
FT   HELIX       121    134
SQ   SEQUENCE   576 AA;  60293 MW;  68DD433F3168E975 CRC64;
     MSTSSLRRQM KNIVHNYSEA EIKVREATSN DPWGPSSSLM SEIADLTYNV VAFSEIMSMI
     WKRLNDHGKN WRHVYKAMTL MEYLIKTGSE RVSQQCKENM YAVQTLKDFQ YVDRDGKDQG
     VNVREKAKQL VALLRDEDRL REERAHALKT KEKLAQTATA SSAAVGSGPP PEAEQAWPQS
     SGEEELQLQL ALAMSKEEAD QPPSCGPEDD AQLQLALSLS REEHDKEERI RRGDDLRLQM
     AIEESKRETG GKEESSLMDL ADVFTAPAPA PTTDPWGGPA PMAAAVPTAA PTSDPWGGPP
     VPPAADPWGG PAPTPASGDP WRPAAPAGPS VDPWGGTPAP AAGEGPTPDP WGSSDGGVPV
     SGPSASDPWT PAPAFSDPWG GSPAKPSTNG TTAAGGFDTE PDEFSDFDRL RTALPTSGSS
     AGELELLAGE VPARSPGAFD MSGVRGSLAE AVGSPPPAAT PTPTPPTRKT PESFLGPNAA
     LVDLDSLVSR PGPTPPGAKA SNPFLPGGGP ATGPSVTNPF QPAPPATLTL NQLRLSPVPP
     VPGAPPTYIS PLGGGPGLPP MMPPGPPAPN TNPFLL
//
ID   EPN2_HUMAN              Reviewed;         641 AA.
AC   O95208; O95207; Q9H7Z2; Q9UPT7;
DT   16-JAN-2004, integrated into UniProtKB/Swiss-Prot.
DT   16-DEC-2008, sequence version 3.
DT   11-JUL-2012, entry version 102.
DE   RecName: Full=Epsin-2;
DE   AltName: Full=EPS-15-interacting protein 2;
GN   Name=EPN2; Synonyms=KIAA1065;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), FUNCTION, INTERACTION
RP   WITH AP-2 AND CLATHRIN, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND
RP   VARIANT ALA-401.
RC   TISSUE=Brain;
RX   MEDLINE=20036528; PubMed=10567358; DOI=10.1074/jbc.274.48.33959;
RA   Rosenthal J.A., Chen H., Slepnev V.I., Pellegrini L., Salcini A.E.,
RA   Di Fiore P.P., De Camilli P.;
RT   "The epsins define a family of proteins that interact with components
RT   of the clathrin coat and contain a new protein module.";
RL   J. Biol. Chem. 274:33959-33965(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   ALA-401.
RC   TISSUE=Brain;
RX   MEDLINE=99397452; PubMed=10470851; DOI=10.1093/dnares/6.3.197;
RA   Kikuno R., Nagase T., Ishikawa K., Hirosawa M., Miyajima N.,
RA   Tanaka A., Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XIV.
RT   The complete sequences of 100 new cDNA clones from brain which code
RT   for large proteins in vitro.";
RL   DNA Res. 6:197-205(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R.,
RA   Gnerre S., Goldstein S., Grafham D.V., Grocock R., Hafez N.,
RA   Hagopian D.S., Hart E., Norman C.H., Humphray S., Jaffe D.B.,
RA   Jones M., Kamal M., Khodiyar V.K., LaButti K., Laird G., Lehoczky J.,
RA   Liu X., Lokyitsang T., Loveland J., Lui A., Macdonald P., Major J.E.,
RA   Matthews L., Mauceli E., McCarroll S.A., Mihalev A.H., Mudge J.,
RA   Nguyen C., Nicol R., O'Leary S.B., Osoegawa K., Schwartz D.C.,
RA   Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in
RT   the human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-467 (ISOFORM 3), AND
RP   VARIANT ALA-401.
RC   TISSUE=Embryo;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-192 AND SER-195, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-492, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Embryonic kidney;
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
CC   -!- FUNCTION: Plays a role in the formation of clathrin-coated
CC       invaginations and endocytosis.
CC   -!- SUBUNIT: Binds EPS15 (By similarity). Binds AP-2 and clathrin.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Cytoplasmic vesicle, clathrin-
CC       coated vesicle. Note=In punctate structures throughout the cell,
CC       associated with clathrin-coated vesicles, and particularly
CC       concentrated in the region of the Golgi complex.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1; Synonyms=2b;
CC         IsoId=O95208-1; Sequence=Displayed;
CC       Name=2; Synonyms=2a;
CC         IsoId=O95208-2; Sequence=VSP_009155;
CC       Name=3;
CC         IsoId=O95208-3; Sequence=VSP_009154, VSP_009155;
CC         Note=No experimental confirmation available;
CC   -!- TISSUE SPECIFICITY: Highest expression is found in brain. Detected
CC       at lower levels in lung and liver.
CC   -!- DOMAIN: The NPF repeat domain is involved in EPS15 binding.
CC   -!- DOMAIN: The DPW repeat domain is involved in AP-2 and clathrin
CC       binding.
CC   -!- PTM: Ubiquitinated (By similarity).
CC   -!- SIMILARITY: Belongs to the epsin family.
CC   -!- SIMILARITY: Contains 1 ENTH (epsin N-terminal homology) domain.
CC   -!- SIMILARITY: Contains 2 UIM (ubiquitin-interacting motif) repeats.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA83017.2; Type=Erroneous initiation;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF062084; AAC78608.1; -; mRNA.
DR   EMBL; AF062085; AAC78609.1; -; mRNA.
DR   EMBL; AB028988; BAA83017.2; ALT_INIT; mRNA.
DR   EMBL; AC106017; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC124066; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AK024115; BAB14831.1; -; mRNA.
DR   IPI; IPI00397379; -.
DR   IPI; IPI00397381; -.
DR   IPI; IPI00915293; -.
DR   RefSeq; NP_055779.2; NM_014964.4.
DR   UniGene; Hs.730624; -.
DR   ProteinModelPortal; O95208; -.
DR   SMR; O95208; 1-144.
DR   STRING; O95208; -.
DR   PhosphoSite; O95208; -.
DR   PRIDE; O95208; -.
DR   Ensembl; ENST00000314728; ENSP00000320543; ENSG00000072134.
DR   GeneID; 22905; -.
DR   KEGG; hsa:22905; -.
DR   UCSC; uc002gvd.4; human.
DR   CTD; 22905; -.
DR   GeneCards; GC17P019140; -.
DR   H-InvDB; HIX0013614; -.
DR   HGNC; HGNC:18639; EPN2.
DR   MIM; 607263; gene.
DR   neXtProt; NX_O95208; -.
DR   PharmGKB; PA38615; -.
DR   eggNOG; NOG263730; -.
DR   GeneTree; ENSGT00550000074611; -.
DR   HOGENOM; HOG000008298; -.
DR   HOVERGEN; HBG006690; -.
DR   InParanoid; O95208; -.
DR   KO; K12471; -.
DR   OMA; NGDWSQP; -.
DR   OrthoDB; EOG4HMJ9P; -.
DR   PhylomeDB; O95208; -.
DR   NextBio; 43557; -.
DR   PMAP-CutDB; O95208; -.
DR   ArrayExpress; O95208; -.
DR   Bgee; O95208; -.
DR   CleanEx; HS_EPN2; -.
DR   Genevestigator; O95208; -.
DR   GermOnline; ENSG00000072134; Homo sapiens.
DR   GO; GO:0030128; C:clathrin coat of endocytic vesicle; IEA:Compara.
DR   GO; GO:0008289; F:lipid binding; IEA:UniProtKB-KW.
DR   GO; GO:0006897; P:endocytosis; IEA:UniProtKB-KW.
DR   GO; GO:0030100; P:regulation of endocytosis; IEA:Compara.
DR   Gene3D; G3DSA:1.25.40.90; ENTH_VHS; 1.
DR   InterPro; IPR008942; ENTH_VHS.
DR   InterPro; IPR013809; Epsin-like_N.
DR   InterPro; IPR001026; Epsin_dom_N.
DR   InterPro; IPR003903; Ubiquitin-int_motif.
DR   Pfam; PF01417; ENTH; 1.
DR   SMART; SM00273; ENTH; 1.
DR   SMART; SM00726; UIM; 2.
DR   SUPFAM; SSF48464; ENTH_VHS; 1.
DR   PROSITE; PS50942; ENTH; 1.
DR   PROSITE; PS50330; UIM; 2.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Cytoplasm;
KW   Cytoplasmic vesicle; Endocytosis; Lipid-binding; Phosphoprotein;
KW   Polymorphism; Reference proteome; Repeat; Ubl conjugation.
FT   CHAIN         1    641       Epsin-2.
FT                                /FTId=PRO_0000074516.
FT   DOMAIN       12    144       ENTH.
FT   REPEAT      275    294       UIM 1.
FT   REPEAT      300    319       UIM 2.
FT   REPEAT      352    354       1.
FT   REPEAT      364    366       2.
FT   REPEAT      377    379       3.
FT   REPEAT      391    393       4.
FT   REPEAT      409    411       5.
FT   REPEAT      427    429       6.
FT   REPEAT      537    539       1.
FT   REPEAT      552    554       2.
FT   REPEAT      637    639       3.
FT   REGION      352    639       6 X 3 AA repeats of [DE]-P-W.
FT   REGION      537    639       3 X 3 AA repeats of N-P-F.
FT   BINDING       8      8       Phosphatidylinositol lipid headgroup (By
FT                                similarity).
FT   BINDING      11     11       Phosphatidylinositol lipid headgroup (By
FT                                similarity).
FT   BINDING      25     25       Phosphatidylinositol lipid headgroup (By
FT                                similarity).
FT   BINDING      30     30       Phosphatidylinositol lipid headgroup (By
FT                                similarity).
FT   BINDING      63     63       Phosphatidylinositol lipid headgroup (By
FT                                similarity).
FT   BINDING      73     73       Phosphatidylinositol lipid headgroup (By
FT                                similarity).
FT   MOD_RES     173    173       Phosphoserine (By similarity).
FT   MOD_RES     182    182       Phosphoserine (By similarity).
FT   MOD_RES     192    192       Phosphoserine.
FT   MOD_RES     195    195       Phosphoserine.
FT   MOD_RES     485    485       Phosphothreonine (By similarity).
FT   MOD_RES     486    486       Phosphoserine (By similarity).
FT   MOD_RES     492    492       Phosphoserine.
FT   VAR_SEQ       1     39       Missing (in isoform 3).
FT                                /FTId=VSP_009154.
FT   VAR_SEQ     199    256       Missing (in isoform 2 and isoform 3).
FT                                /FTId=VSP_009155.
FT   VARIANT     401    401       V -> A (in dbSNP:rs6587220).
FT                                /FTId=VAR_053080.
FT   VARIANT     531    531       P -> T (in dbSNP:rs1062727).
FT                                /FTId=VAR_047923.
FT   VARIANT     532    532       P -> T (in dbSNP:rs1062727).
FT                                /FTId=VAR_053081.
FT   CONFLICT    256    256       A -> AS (in Ref. 1; AAC78609).
FT   CONFLICT    547    547       T -> N (in Ref. 1; AAC78608/AAC78609).
SQ   SEQUENCE   641 AA;  68482 MW;  0BE24CBD824F357A CRC64;
     MTTSSIRRQM KNIVNNYSEA EIKVREATSN DPWGPSSSLM TEIADLTYNV VAFSEIMSMV
     WKRLNDHGKN WRHVYKALTL LDYLIKTGSE RVAQQCRENI FAIQTLKDFQ YIDRDGKDQG
     INVREKSKQL VALLKDEERL KAERAQALKT KERMAQVATG MGSNQITFGR GSSQPNLSTS
     HSEQEYGKAG GSPASYHGSP EASLCPQHRT GAPLGQSEEL QPLSQRHPFL PHLGLASRPN
     GDWSQPCLTC DRAARATSPR VSSELEQARP QTSGEEELQL QLALAMSREV AEQEERLRRG
     DDLRLQMALE ESRRDTVKIP KKKEHGSLPQ QTTLLDLMDA LPSSGPAAQK AEPWGPSAST
     NQTNPWGGPA APASTSDPWP SFGTKPAASI DPWGVPTGAT VQSVPKNSDP WAASQQPASS
     AGKRASDAWG AVSTTKPVSV SGSFELFSNL NGTIKDDFSE FDNLRTSKKT AESVTSLPSQ
     NNGTTSPDPF ESQPLTVASS KPSSARKTPE SFLGPNAALV NLDSLVTRPA PPAQSLNPFL
     APGAPATSAP VNPFQVNQPQ PLTLNQLRGS PVLGTSTSFG PGPGVESMAV ASMTSAAPQP
     ALGATGSSLT PLGPAMMNMV GSVGIPPSAA QATGTTNPFL L
//
ID   EPN3_HUMAN              Reviewed;         632 AA.
AC   Q9H201; A8K6J3; A8KAB2; Q9BVN6; Q9NWK2;
DT   16-JAN-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   13-JUN-2012, entry version 97.
DE   RecName: Full=Epsin-3;
DE   AltName: Full=EPS-15-interacting protein 3;
GN   Name=EPN3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), INDUCTION, TISSUE SPECIFICITY,
RP   AND SUBCELLULAR LOCATION.
RC   TISSUE=Keratinocyte;
RX   MEDLINE=21369897; PubMed=11359770; DOI=10.1074/jbc.M101663200;
RA   Spradling K.D., McDaniel A.E., Lohi J., Pilcher B.K.;
RT   "Epsin 3 is a novel extracellular matrix-induced transcript specific
RT   to wounded epithelia.";
RL   J. Biol. Chem. 276:29257-29267(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   THR-544.
RC   TISSUE=Colon, Placenta, and Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-17; TYR-176 AND TYR-186,
RP   AND MASS SPECTROMETRY.
RC   TISSUE=Mammary epithelium;
RX   PubMed=19534553; DOI=10.1021/pr900044c;
RA   Heibeck T.H., Ding S.-J., Opresko L.K., Zhao R., Schepmoes A.A.,
RA   Yang F., Tolmachev A.V., Monroe M.E., Camp D.G. II, Smith R.D.,
RA   Wiley H.S., Qian W.-J.;
RT   "An extensive survey of tyrosine phosphorylation revealing new sites
RT   in human mammary epithelial cells.";
RL   J. Proteome Res. 8:3852-3861(2009).
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Cytoplasm, perinuclear region.
CC       Cytoplasmic vesicle, clathrin-coated vesicle. Nucleus (Probable).
CC       Note=Concentrated in the perinuclear region and associated with
CC       clathrin-coated vesicles close to the cell periphery. May shuttle
CC       to the nucleus.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9H201-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9H201-2; Sequence=VSP_009158, VSP_009159;
CC         Note=No experimental confirmation available. May be produced at
CC         very low levels due to a premature stop codon in the mRNA,
CC         leading to nonsense-mediated mRNA decay;
CC   -!- TISSUE SPECIFICITY: Detected in migrating keratinocytes from
CC       wounded skin, but not in differentiating keratinocytes or in
CC       normal skin. Detected in chronic wounds, basal cell carcinoma and
CC       ulcerative colitis.
CC   -!- INDUCTION: In keratinocytes, by wounding or contact with collagen.
CC   -!- SIMILARITY: Belongs to the epsin family.
CC   -!- SIMILARITY: Contains 1 ENTH (epsin N-terminal homology) domain.
CC   -!- SIMILARITY: Contains 2 UIM (ubiquitin-interacting motif) repeats.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF324241; AAG45223.1; -; mRNA.
DR   EMBL; AK000785; BAA91378.1; -; mRNA.
DR   EMBL; AK291658; BAF84347.1; -; mRNA.
DR   EMBL; AK292977; BAF85666.1; -; mRNA.
DR   EMBL; CH471109; EAW94607.1; -; Genomic_DNA.
DR   EMBL; BC001038; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; BC051365; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; BC077722; -; NOT_ANNOTATED_CDS; mRNA.
DR   IPI; IPI00300584; -.
DR   IPI; IPI00386833; -.
DR   RefSeq; NP_060427.2; NM_017957.2.
DR   UniGene; Hs.670090; -.
DR   ProteinModelPortal; Q9H201; -.
DR   SMR; Q9H201; 12-155.
DR   MINT; MINT-1199053; -.
DR   STRING; Q9H201; -.
DR   PhosphoSite; Q9H201; -.
DR   DMDM; 41017054; -.
DR   PRIDE; Q9H201; -.
DR   Ensembl; ENST00000268933; ENSP00000268933; ENSG00000049283.
DR   Ensembl; ENST00000510045; ENSP00000421933; ENSG00000049283.
DR   GeneID; 55040; -.
DR   KEGG; hsa:55040; -.
DR   UCSC; uc002ira.4; human.
DR   CTD; 55040; -.
DR   GeneCards; GC17P048610; -.
DR   HGNC; HGNC:18235; EPN3.
DR   MIM; 607264; gene.
DR   neXtProt; NX_Q9H201; -.
DR   PharmGKB; PA38513; -.
DR   eggNOG; NOG263730; -.
DR   GeneTree; ENSGT00550000074611; -.
DR   HOGENOM; HOG000008298; -.
DR   HOVERGEN; HBG006690; -.
DR   InParanoid; Q9H201; -.
DR   KO; K12471; -.
DR   OrthoDB; EOG4SF97B; -.
DR   PhylomeDB; Q9H201; -.
DR   NextBio; 58495; -.
DR   ArrayExpress; Q9H201; -.
DR   Bgee; Q9H201; -.
DR   CleanEx; HS_EPN3; -.
DR   Genevestigator; Q9H201; -.
DR   GermOnline; ENSG00000049283; Homo sapiens.
DR   GO; GO:0030136; C:clathrin-coated vesicle; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0008289; F:lipid binding; IEA:UniProtKB-KW.
DR   Gene3D; G3DSA:1.25.40.90; ENTH_VHS; 1.
DR   InterPro; IPR008942; ENTH_VHS.
DR   InterPro; IPR013809; Epsin-like_N.
DR   InterPro; IPR001026; Epsin_dom_N.
DR   InterPro; IPR003903; Ubiquitin-int_motif.
DR   Pfam; PF01417; ENTH; 1.
DR   Pfam; PF02809; UIM; 2.
DR   SMART; SM00273; ENTH; 1.
DR   SMART; SM00726; UIM; 2.
DR   SUPFAM; SSF48464; ENTH_VHS; 1.
DR   PROSITE; PS50942; ENTH; 1.
DR   PROSITE; PS50330; UIM; 2.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Cytoplasm;
KW   Cytoplasmic vesicle; Lipid-binding; Nucleus; Phosphoprotein;
KW   Polymorphism; Reference proteome; Repeat.
FT   CHAIN         1    632       Epsin-3.
FT                                /FTId=PRO_0000074519.
FT   DOMAIN       12    144       ENTH.
FT   REPEAT      209    228       UIM 1.
FT   REPEAT      236    255       UIM 2.
FT   REPEAT      321    323       1.
FT   REPEAT      344    346       2.
FT   REPEAT      371    373       3.
FT   REPEAT      387    389       4.
FT   REPEAT      404    406       5.
FT   REPEAT      524    526       1.
FT   REPEAT      537    539       2.
FT   REPEAT      629    631       3.
FT   REGION      321    406       5 X 3 AA repeats of [DE]-P-W.
FT   REGION      524    631       3 X 3 AA repeats of N-P-F.
FT   BINDING       8      8       Phosphatidylinositol lipid headgroup (By
FT                                similarity).
FT   BINDING      11     11       Phosphatidylinositol lipid headgroup (By
FT                                similarity).
FT   BINDING      25     25       Phosphatidylinositol lipid headgroup (By
FT                                similarity).
FT   BINDING      30     30       Phosphatidylinositol lipid headgroup (By
FT                                similarity).
FT   BINDING      63     63       Phosphatidylinositol lipid headgroup (By
FT                                similarity).
FT   BINDING      73     73       Phosphatidylinositol lipid headgroup (By
FT                                similarity).
FT   MOD_RES      17     17       Phosphotyrosine.
FT   MOD_RES     176    176       Phosphotyrosine.
FT   MOD_RES     182    182       Phosphoserine (By similarity).
FT   MOD_RES     186    186       Phosphotyrosine.
FT   MOD_RES     393    393       Phosphoserine (By similarity).
FT   VAR_SEQ     188    208       SSSSSPRYTSDLEQARPQTSG -> CPASDVRGRGTAAAAG
FT                                PRHEP (in isoform 2).
FT                                /FTId=VSP_009158.
FT   VAR_SEQ     209    632       Missing (in isoform 2).
FT                                /FTId=VSP_009159.
FT   VARIANT     544    544       P -> T (in dbSNP:rs4794159).
FT                                /FTId=VAR_059973.
FT   CONFLICT    375    375       R -> K (in Ref. 2; BAF85666).
FT   CONFLICT    396    396       H -> Y (in Ref. 2; BAA91378).
FT   CONFLICT    417    417       G -> S (in Ref. 2; BAF85666).
SQ   SEQUENCE   632 AA;  68222 MW;  13940F2FBD6215D0 CRC64;
     MTTSALRRQV KNIVHNYSEA EIKVREATSN DPWGPPSSLM SEIADLTFNT VAFTEVMGML
     WRRLNDSGKN WRHVYKALTL LDYLLKTGSE RVAHQCRENL YTIQTLKDFQ YIDRDGKDQG
     VNVREKVKQV MALLKDEERL RQERTHALKT KERMALEGIG IGSGQLGFSR RYGEDYSRSR
     GSPSSYNSSS SSPRYTSDLE QARPQTSGEE ELQLQLALAM SREEAEKPVP PASHRDEDLQ
     LQLALRLSRQ EHEKEVRSWQ GDGSPMANGA GAVVHHQRDR EPEREERKEE EKLKTSQSSI
     LDLADIFVPA LAPPSTHCSA DPWDIPGFRP NTEASGSSWG PSADPWSPIP SGTVLSRSQP
     WDLTPMLSSS EPWGRTPVLP AGPPTTDPWA LNSPHHKLPS TGADPWGASL ETSDTPGGAS
     TFDPFAKPPE STETKEGLEQ ALPSGKPSSP VELDLFGDPS PSSKQNGTKE PDALDLGILG
     EALTQPSKEA RACRTPESFL GPSASSLVNL DSLVKAPQVA KTRNPFLTGL SAPSPTNPFG
     AGEPGRPTLN QMRTGSPALG LAGGPVGAPL GSMTYSASLP LPLSSVPAGL TLPASVSVFP
     QAGAFAPQPL LPTPSSAGPR PPPPQTGTNP FL
//
ID   EPN4_HUMAN              Reviewed;         625 AA.
AC   Q14677; B7Z6F8; D3DQJ6; Q8NAF1; Q96E05;
DT   16-JAN-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   11-JUL-2012, entry version 122.
DE   RecName: Full=Clathrin interactor 1;
DE   AltName: Full=Clathrin-interacting protein localized in the trans-Golgi region;
DE            Short=Clint;
DE   AltName: Full=Enthoprotin;
DE   AltName: Full=Epsin-4;
DE   AltName: Full=Epsin-related protein;
DE            Short=EpsinR;
GN   Name=CLINT1; Synonyms=ENTH, EPN4, EPNR, KIAA0171;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], PROTEIN SEQUENCE OF 14-27; 30-49;
RP   110-129; 134-146; 157-171; 201-218; 248-274 AND 284-297 (ISOFORM 1),
RP   MASS SPECTROMETRY, INTERACTION WITH CLATHRIN; AP1G1 AND GGA2, AND
RP   SUBCELLULAR LOCATION.
RX   MEDLINE=22202360; PubMed=12213833; DOI=10.1083/jcb.200205078;
RA   Wasiak S., Legendre-Guillemin V., Puertollano R., Blondeau F.,
RA   Girard M., de Heuvel E., Boismenu D., Bell A.W., Bonifacino J.S.,
RA   McPherson P.S.;
RT   "Enthoprotin: a novel clathrin-associated protein identified through
RT   subcellular proteomics.";
RL   J. Cell Biol. 158:855-862(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Hong W.;
RT   "KIAA0171 as a new member (epsin 4) of the epsin family.";
RL   Submitted (OCT-2001) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Bone marrow;
RX   MEDLINE=96281124; PubMed=8724849; DOI=10.1093/dnares/3.1.17;
RA   Nagase T., Seki N., Ishikawa K., Tanaka A., Nomura N.;
RT   "Prediction of the coding sequences of unidentified human genes. V.
RT   The coding sequences of 40 new genes (KIAA0161-KIAA0200) deduced by
RT   analysis of cDNA clones from human cell line KG-1.";
RL   DNA Res. 3:17-24(1996).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3).
RC   TISSUE=Placenta, and Small intestine;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15372022; DOI=10.1038/nature02919;
RA   Schmutz J., Martin J., Terry A., Couronne O., Grimwood J., Lowry S.,
RA   Gordon L.A., Scott D., Xie G., Huang W., Hellsten U., Tran-Gyamfi M.,
RA   She X., Prabhakar S., Aerts A., Altherr M., Bajorek E., Black S.,
RA   Branscomb E., Caoile C., Challacombe J.F., Chan Y.M., Denys M.,
RA   Detter J.C., Escobar J., Flowers D., Fotopulos D., Glavina T.,
RA   Gomez M., Gonzales E., Goodstein D., Grigoriev I., Groza M.,
RA   Hammon N., Hawkins T., Haydu L., Israni S., Jett J., Kadner K.,
RA   Kimball H., Kobayashi A., Lopez F., Lou Y., Martinez D., Medina C.,
RA   Morgan J., Nandkeshwar R., Noonan J.P., Pitluck S., Pollard M.,
RA   Predki P., Priest J., Ramirez L., Retterer J., Rodriguez A.,
RA   Rogers S., Salamov A., Salazar A., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wheeler J., Wu K., Yang J., Dickson M.,
RA   Cheng J.-F., Eichler E.E., Olsen A., Pennacchio L.A., Rokhsar D.S.,
RA   Richardson P., Lucas S.M., Myers R.M., Rubin E.M.;
RT   "The DNA sequence and comparative analysis of human chromosome 5.";
RL   Nature 431:268-274(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Lung, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   FUNCTION, MUTAGENESIS OF 423-LEU--LEU-426, INTERACTION WITH CLATHRIN;
RP   AP1G1 AND AP-2, TISSUE SPECIFICITY, AND SUBCELLULAR LOCATION.
RX   PubMed=12429846; DOI=10.1091/mbc.E02-03-0171;
RA   Kalthoff C., Groos S., Kohl R., Mahrhold S., Ungewickell E.J.;
RT   "Clint: a novel clathrin-binding ENTH-domain protein at the Golgi.";
RL   Mol. Biol. Cell 13:4060-4073(2002).
RN   [9]
RP   FUNCTION, TISSUE SPECIFICITY, SUBCELLULAR LOCATION, MUTAGENESIS OF
RP   ASP-34; ASP-349; ASP-371 AND ASP-422, AND INTERACTION WITH AP1G1; AP-2
RP   AND CLATHRIN.
RX   PubMed=12538641; DOI=10.1083/jcb.200208023;
RA   Mills I.G., Praefcke G.J.K., Vallis Y., Peter B.J., Olesen L.E.,
RA   Gallop J.L., Butler P.J.G., Evans P.R., McMahon H.T.;
RT   "EpsinR: an AP1/clathrin interacting protein involved in vesicle
RT   trafficking.";
RL   J. Cell Biol. 160:213-222(2003).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-227; SER-232; SER-234
RP   AND SER-299, AND MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-22 AND SER-26, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17924679; DOI=10.1021/pr070152u;
RA   Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.;
RT   "Improved titanium dioxide enrichment of phosphopeptides from HeLa
RT   cells and high confident phosphopeptide identification by cross-
RT   validation of MS/MS and MS/MS/MS spectra.";
RL   J. Proteome Res. 6:4150-4162(2007).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-245 AND THR-272, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=Embryonic kidney;
RX   PubMed=17287340; DOI=10.1073/pnas.0611217104;
RA   Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.;
RT   "Global proteomic profiling of phosphopeptides using electron transfer
RT   dissociation tandem mass spectrometry.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007).
RN   [13]
RP   POSSIBLE INVOLVEMENT IN SCZD1.
RX   PubMed=15793701; DOI=10.1086/430095;
RA   Pimm J., McQuillin A., Thirumalai S., Lawrence J., Quested D.,
RA   Bass N., Lamb G., Moorey H., Datta S.R., Kalsi G., Badacsonyi A.,
RA   Kelly K., Morgan J., Punukollu B., Curtis D., Gurling H.;
RT   "The Epsin 4 gene on chromosome 5q, which encodes the clathrin-
RT   associated protein enthoprotin, is involved in the genetic
RT   susceptibility to schizophrenia.";
RL   Am. J. Hum. Genet. 76:902-907(2005).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-245 AND SER-299, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-245 AND SER-299, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-227, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Liver;
RX   PubMed=18318008; DOI=10.1002/pmic.200700884;
RA   Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,
RA   Zou H., Gu J.;
RT   "Large-scale phosphoproteome analysis of human liver tissue by
RT   enrichment and fractionation of phosphopeptides with strong anion
RT   exchange chromatography.";
RL   Proteomics 8:1346-1361(2008).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-299; SER-305 AND
RP   SER-312, AND MASS SPECTROMETRY.
RC   TISSUE=Embryonic kidney;
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-166 AND SER-299, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
CC   -!- FUNCTION: Binds to membranes enriched in phosphatidylinositol 4,5-
CC       bisphosphate (PtdIns(4,5)P2). May have a role in transport via
CC       clathrin-coated vesicles from the trans-Golgi network to
CC       endosomes. Stimulates clathrin assembly.
CC   -!- SUBUNIT: Binds clathrin heavy chain, GGA2, AP-2 and AP1G1.
CC   -!- INTERACTION:
CC       Q9H0R8:GABARAPL1; NbExp=2; IntAct=EBI-1171113, EBI-746969;
CC       Q9GZQ8:MAP1LC3B; NbExp=2; IntAct=EBI-1171113, EBI-373144;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Cytoplasm, perinuclear region.
CC       Membrane; Peripheral membrane protein. Cytoplasmic vesicle,
CC       clathrin-coated vesicle. Note=Found throughout the cell, with the
CC       exception of the cell surface. Concentrated in the perinuclear
CC       region and associated with clathrin-coated vesicles close to the
CC       trans-Golgi network.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q14677-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q14677-2; Sequence=VSP_009160, VSP_009161;
CC       Name=3;
CC         IsoId=Q14677-3; Sequence=VSP_043302;
CC         Note=No experimental confirmation available;
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed at low to intermediate
CC       levels.
CC   -!- POLYMORPHISM: Genetic variations in CLINT1 may contribute to
CC       susceptibility to schizophrenia and psychotic disorders in some
CC       populations.
CC   -!- SIMILARITY: Belongs to the epsin family.
CC   -!- SIMILARITY: Contains 1 ENTH (epsin N-terminal homology) domain.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA11488.2; Type=Erroneous initiation;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BK000414; DAA00062.1; -; Genomic_DNA.
DR   EMBL; AF434813; AAL30768.1; -; mRNA.
DR   EMBL; D79993; BAA11488.2; ALT_INIT; mRNA.
DR   EMBL; AK092765; BAC03971.1; -; mRNA.
DR   EMBL; AK300257; BAH13244.1; -; mRNA.
DR   EMBL; AC011394; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC026407; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471062; EAW61585.1; -; Genomic_DNA.
DR   EMBL; CH471062; EAW61588.1; -; Genomic_DNA.
DR   EMBL; BC004467; AAH04467.1; -; mRNA.
DR   EMBL; BC013091; AAH13091.1; -; mRNA.
DR   IPI; IPI00291930; -.
DR   IPI; IPI00397519; -.
DR   IPI; IPI00975549; -.
DR   RefSeq; NP_001182484.1; NM_001195555.1.
DR   RefSeq; NP_001182485.1; NM_001195556.1.
DR   RefSeq; NP_055481.1; NM_014666.3.
DR   UniGene; Hs.644000; -.
DR   PDB; 1XGW; X-ray; 1.90 A; A=1-165.
DR   PDB; 2QY7; X-ray; 2.00 A; A/B/C=20-166.
DR   PDB; 2V8S; X-ray; 2.22 A; E=20-166.
DR   PDBsum; 1XGW; -.
DR   PDBsum; 2QY7; -.
DR   PDBsum; 2V8S; -.
DR   ProteinModelPortal; Q14677; -.
DR   SMR; Q14677; 17-152.
DR   IntAct; Q14677; 17.
DR   STRING; Q14677; -.
DR   PhosphoSite; Q14677; -.
DR   DMDM; 41016993; -.
DR   PRIDE; Q14677; -.
DR   Ensembl; ENST00000296951; ENSP00000296951; ENSG00000113282.
DR   Ensembl; ENST00000411809; ENSP00000388340; ENSG00000113282.
DR   Ensembl; ENST00000523094; ENSP00000429345; ENSG00000113282.
DR   Ensembl; ENST00000523908; ENSP00000429824; ENSG00000113282.
DR   Ensembl; ENST00000530742; ENSP00000433419; ENSG00000113282.
DR   GeneID; 9685; -.
DR   KEGG; hsa:9685; -.
DR   UCSC; uc003lxi.2; human.
DR   UCSC; uc003lxj.2; human.
DR   CTD; 9685; -.
DR   GeneCards; GC05M157212; -.
DR   HGNC; HGNC:23186; CLINT1.
DR   HPA; HPA043280; -.
DR   MIM; 607265; gene.
DR   neXtProt; NX_Q14677; -.
DR   Orphanet; 3140; Schizophrenia.
DR   PharmGKB; PA145149115; -.
DR   eggNOG; NOG290795; -.
DR   GeneTree; ENSGT00550000074611; -.
DR   HOGENOM; HOG000082415; -.
DR   HOVERGEN; HBG048921; -.
DR   InParanoid; Q14677; -.
DR   OMA; GMPNLAM; -.
DR   OrthoDB; EOG4BK53R; -.
DR   PhylomeDB; Q14677; -.
DR   Reactome; REACT_11123; Membrane Trafficking.
DR   EvolutionaryTrace; Q14677; -.
DR   NextBio; 36372; -.
DR   ArrayExpress; Q14677; -.
DR   Bgee; Q14677; -.
DR   CleanEx; HS_CLINT1; -.
DR   Genevestigator; Q14677; -.
DR   GermOnline; ENSG00000113282; Homo sapiens.
DR   GO; GO:0030136; C:clathrin-coated vesicle; IEA:UniProtKB-SubCell.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0008289; F:lipid binding; IEA:UniProtKB-KW.
DR   GO; GO:0016044; P:cellular membrane organization; TAS:Reactome.
DR   GO; GO:0006897; P:endocytosis; IEA:UniProtKB-KW.
DR   GO; GO:0006892; P:post-Golgi vesicle-mediated transport; TAS:Reactome.
DR   Gene3D; G3DSA:1.25.40.90; ENTH_VHS; 1.
DR   InterPro; IPR008942; ENTH_VHS.
DR   InterPro; IPR013809; Epsin-like_N.
DR   InterPro; IPR001026; Epsin_dom_N.
DR   Pfam; PF01417; ENTH; 1.
DR   SMART; SM00273; ENTH; 1.
DR   SUPFAM; SSF48464; ENTH_VHS; 1.
DR   PROSITE; PS50942; ENTH; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome; Cytoplasm;
KW   Cytoplasmic vesicle; Direct protein sequencing; Endocytosis;
KW   Lipid-binding; Membrane; Phosphoprotein; Reference proteome.
FT   CHAIN         1    625       Clathrin interactor 1.
FT                                /FTId=PRO_0000074521.
FT   DOMAIN       16    149       ENTH.
FT   COMPBIAS    549    605       Met-rich.
FT   BINDING      29     29       Phosphatidylinositol lipid headgroup (By
FT                                similarity).
FT   BINDING      67     67       Phosphatidylinositol lipid headgroup (By
FT                                similarity).
FT   MOD_RES      22     22       Phosphoserine.
FT   MOD_RES      26     26       Phosphoserine.
FT   MOD_RES     163    163       Phosphoserine (By similarity).
FT   MOD_RES     166    166       Phosphoserine.
FT   MOD_RES     227    227       Phosphoserine.
FT   MOD_RES     232    232       Phosphoserine.
FT   MOD_RES     234    234       Phosphoserine.
FT   MOD_RES     245    245       Phosphoserine.
FT   MOD_RES     272    272       Phosphothreonine.
FT   MOD_RES     299    299       Phosphoserine.
FT   MOD_RES     305    305       Phosphoserine.
FT   MOD_RES     312    312       Phosphoserine.
FT   VAR_SEQ       1     18       Missing (in isoform 2).
FT                                /FTId=VSP_009160.
FT   VAR_SEQ     459    459       S -> SQPLQNVSTVLQKPNPLYN (in isoform 3).
FT                                /FTId=VSP_043302.
FT   VAR_SEQ     460    460       Q -> QPLQNVSTVLQKPNPLYNQ (in isoform 2).
FT                                /FTId=VSP_009161.
FT   MUTAGEN      29     29       R->L: Reduces lipid binding. Abolishes
FT                                lipid binding; when associated with G-34.
FT   MUTAGEN      34     34       D->G: Abolishes lipid binding; when
FT                                associated with L-29.
FT   MUTAGEN     349    349       D->R: Decreases AP-1 and AP-2 binding.
FT   MUTAGEN     371    371       D->R: Slightly decreases AP-1 binding.
FT   MUTAGEN     422    422       D->R: Strongly decreases clathrin
FT                                binding.
FT   MUTAGEN     423    426       LFDL->AFAA: Strongly reduces clathrin
FT                                binding.
FT   CONFLICT    476    476       T -> A (in Ref. 4; BAC03971).
FT   HELIX        23     31
FT   STRAND       33     37
FT   HELIX        41     50
FT   TURN         54     56
FT   HELIX        57     69
FT   HELIX        76     92
FT   HELIX        95    103
FT   HELIX       105    109
FT   HELIX       110    113
FT   HELIX       125    139
FT   HELIX       142    151
SQ   SEQUENCE   625 AA;  68259 MW;  6C8C6689861E9F0D CRC64;
     MLNMWKVREL VDKATNVVMN YSEIESKVRE ATNDDPWGPS GQLMGEIAKA TFMYEQFPEL
     MNMLWSRMLK DNKKNWRRVY KSLLLLAYLI RNGSERVVTS AREHIYDLRS LENYHFVDEH
     GKDQGINIRQ KVKELVEFAQ DDDRLREERK KAKKNKDKYV GVSSDSVGGF RYSERYDPEP
     KSKWDEEWDK NKSAFPFSDK LGELSDKIGS TIDDTISKFR RKDREDSPER CSDSDEEKKA
     RRGRSPKGEF KDEEETVTTK HIHITQATET TTTRHKRTAN PSKTIDLGAA AHYTGDKASP
     DQNASTHTPQ SSVKTSVPSS KSSGDLVDLF DGTSQSTGGS ADLFGGFADF GSAAASGSFP
     SQVTATSGNG DFGDWSAFNQ APSGPVASSG EFFGSASQPA VELVSGSQSA LGPPPAASNS
     SDLFDLMGSS QATMTSSQSM NFSMMSTNTV GLGLPMSRSQ NTDMVQKSVS KTLPSTWSDP
     SVNISLDNLL PGMQPSKPQQ PSLNTMIQQQ NMQQPMNVMT QSFGAVNLSS PSNMLPVRPQ
     TNALIGGPMP MSMPNVMTGT MGMAPLGNTP MMNQSMMGMN MNIGMSAAGM GLTGTMGMGM
     PNIAMTSGTV QPKQDAFANF ANFSK
//
